Provided by Tiger Trade Technology Pte. Ltd.

Surgery Partners

13.25
-0.1000-0.75%
Post-market: 13.250.00000.00%19:30 EDT
Volume:2.76M
Turnover:36.56M
Market Cap:1.74B
PE:-19.20
High:13.49
Open:13.12
Low:12.97
Close:13.35
52wk High:23.44
52wk Low:11.41
Shares:131.00M
Float Shares:66.72M
Volume Ratio:1.30
T/O Rate:4.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6900
EPS(LYR):-0.6124
ROE:2.32%
ROA:3.66%
PB:1.04
PE(LYR):-21.64

Loading ...

Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Envista Holdings (NVST) and Inventiva (IVA)

TIPRANKS
·
Sep 18

Surgery Partners Divests Hospital Assets to Cut Debt

TIPRANKS
·
Sep 17

GUIDANCE: (SGRY) Surgery Partners Expects 2026 Revenue Range $3.08B to $3.18B, vs. FactSet Est of $3.42B

MT Newswires Live
·
Sep 17

Surgery Partners Pro Forma Net Loss Attributable to Company Widens to $108.2 Million in FY25; Revenue Falls to $2.59 Billion

Reuters
·
Sep 17

Surgery Partners Sees 2026 Revenue USD 3.08 Billion-3.18 Billion, Adjusted Ebitda at Least USD 489 Million

Reuters
·
Sep 17

Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction

THOMSON REUTERS
·
Sep 17

Surgery Partners, - Pro Forma Full-Year 2026 Revenue Guidance $2.60-$2.67 Bln; Adj Ebitda Guidance at Least $414 Mln

THOMSON REUTERS
·
Sep 17

Medical Properties Trust Sells Idaho Hospitals to Intermountain Affiliates for USD 413 Million, Nets USD 371 Million Cash

Reuters
·
Sep 17

Surgery Partners is Maintained at Neutral by JP Morgan

Dow Jones
·
Sep 14

Surgery Partners price target raised to $15 from $14 at JPMorgan

TIPRANKS
·
Sep 14

Barclays Remains a Hold on Surgery Partners (SGRY)

TIPRANKS
·
Aug 28

How Mixed Q2 Results and Slower M&A At Surgery Partners (SGRY) Have Changed Its Investment Story

Simply Wall St.
·
Aug 25

Surgery Partners Director Teresa DeLuca Buys 10,000 Shares Worth $143,500

Reuters
·
Aug 20

Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy?

Simply Wall St.
·
Aug 17

Canada's NeuPath Health Q2 Revenue Falls Despite Record Patient Visits

Reuters
·
Aug 13

Aveanna Healthcare Q2 Revenue Beats on Broad-Based Growth

Reuters
·
Aug 13

Lumexa Imaging Q2 Net Income Turns Positive

Reuters
·
Aug 13

Stereotaxis Q2 Revenue Misses Estimates, Dragged by System Decline

Reuters
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)

TIPRANKS
·
Aug 12

Surgery Partners Price Target Maintained with a $18.00/Share by Cantor Fitzgerald

Dow Jones
·
Aug 11